+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Paclitaxel Market by Type (Endophytic Fungus Synthesis, Semi Synthesis, Total Synthesis), Application (Breast Cancer, Lung Cancer, Ovarian Cancer), End-User - Forecast 2024-2030- Product Image
Global Paclitaxel Market by Type (Endophytic Fungus Synthesis, Semi Synthesis, Total Synthesis), Application (Breast Cancer, Lung Cancer, Ovarian Cancer), End-User - Forecast 2024-2030- Product Image
Sale

Global Paclitaxel Market by Type (Endophytic Fungus Synthesis, Semi Synthesis, Total Synthesis), Application (Breast Cancer, Lung Cancer, Ovarian Cancer), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889266
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Paclitaxel Market size was estimated at USD 424.41 million in 2023, USD 466.21 million in 2024, and is expected to grow at a CAGR of 9.92% to reach USD 822.92 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Paclitaxel Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Paclitaxel Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Paclitaxel Market, highlighting leading vendors and their innovative profiles. These include Alchem International, Apino Pharma Co., Ltd., Avanscure Lifesciences Pvt. Ltd., Corden Pharma International GmbH, Fresenius Kabi AG, Guilin Huiang Biochemistry Pharmaceutical Co., Ltd., Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., Indena S.p.A., Intas Pharmaceuticals Ltd., Intelicure Lifesciences, LGM Pharma, Mac-Chem Products (India) Pvt. Ltd., Novasep Holding SAS, Panacea Biotec, Phyton Biotech, Poly Medicure Ltd., Samyang Holdings Corporation, Teva API, Inc., Trumac Healthcare, and Yunnan Hande Bio-tech Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Paclitaxel Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Endophytic Fungus Synthesis
    • Semi Synthesis
    • Total Synthesis
  • Application
    • Breast Cancer
    • Lung Cancer
    • Ovarian Cancer
  • End-User
    • Clinics
    • Hospitals
    • Oncology Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Paclitaxel Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Paclitaxel Market?
  3. What are the technology trends and regulatory frameworks in the Paclitaxel Market?
  4. What is the market share of the leading vendors in the Paclitaxel Market?
  5. Which modes and strategic moves are suitable for entering the Paclitaxel Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Paclitaxel Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the prevalence of cancer cases
5.1.1.2. Rising healthcare expenditure and improvement in diagnosis and screening of cancer
5.1.1.3. Growing utilization of paclitaxel in chemotherapy and combination therapies
5.1.2. Restraints
5.1.2.1. Adverse health effects and toxicity concerns
5.1.3. Opportunities
5.1.3.1. Advancements in the manufacturing process of bulk paclitaxel
5.1.3.2. Regulatory approvals for the use of paclitaxel as a cancer treatment drug
5.1.4. Challenges
5.1.4.1. High production cost and availability of alternatives
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Paclitaxel Market, by Type
6.1. Introduction
6.2. Endophytic Fungus Synthesis
6.3. Semi Synthesis
6.4. Total Synthesis
7. Paclitaxel Market, by Application
7.1. Introduction
7.2. Breast Cancer
7.3. Lung Cancer
7.4. Ovarian Cancer
8. Paclitaxel Market, by End-User
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Oncology Centers
9. Americas Paclitaxel Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Paclitaxel Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Paclitaxel Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alchem International
13.1.2. Apino Pharma Co., Ltd.
13.1.3. Avanscure Lifesciences Pvt. Ltd.
13.1.4. Corden Pharma International GmbH
13.1.5. Fresenius Kabi AG
13.1.6. Guilin Huiang Biochemistry Pharmaceutical Co., Ltd.
13.1.7. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
13.1.8. Indena S.p.A.
13.1.9. Intas Pharmaceuticals Ltd.
13.1.10. Intelicure Lifesciences
13.1.11. LGM Pharma
13.1.12. Mac-Chem Products (India) Pvt. Ltd.
13.1.13. Novasep Holding SAS
13.1.14. Panacea Biotec
13.1.15. Phyton Biotech
13.1.16. Poly Medicure Ltd.
13.1.17. Samyang Holdings Corporation
13.1.18. Teva API, Inc.
13.1.19. Trumac Healthcare
13.1.20. Yunnan Hande Bio-tech Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. PACLITAXEL MARKET RESEARCH PROCESS
FIGURE 2. PACLITAXEL MARKET SIZE, 2023 VS 2030
FIGURE 3. PACLITAXEL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PACLITAXEL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PACLITAXEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PACLITAXEL MARKET DYNAMICS
FIGURE 7. PACLITAXEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. PACLITAXEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PACLITAXEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. PACLITAXEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PACLITAXEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. PACLITAXEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PACLITAXEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PACLITAXEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PACLITAXEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PACLITAXEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PACLITAXEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PACLITAXEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PACLITAXEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PACLITAXEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PACLITAXEL MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PACLITAXEL MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. PACLITAXEL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PACLITAXEL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PACLITAXEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. PACLITAXEL MARKET SIZE, BY ENDOPHYTIC FUNGUS SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PACLITAXEL MARKET SIZE, BY SEMI SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PACLITAXEL MARKET SIZE, BY TOTAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 10. PACLITAXEL MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PACLITAXEL MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PACLITAXEL MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 14. PACLITAXEL MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PACLITAXEL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PACLITAXEL MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PACLITAXEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. CANADA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. CANADA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. MEXICO PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PACLITAXEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PACLITAXEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. CHINA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CHINA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. INDIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. INDIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. JAPAN PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. THAILAND PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PACLITAXEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EGYPT PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FINLAND PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FRANCE PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. GERMANY PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NORWAY PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. POLAND PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. POLAND PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. QATAR PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. QATAR PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SPAIN PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM PACLITAXEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PACLITAXEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PACLITAXEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. PACLITAXEL MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. PACLITAXEL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. PACLITAXEL MARKET LICENSE & PRICING

Companies Mentioned

  • Alchem International
  • Apino Pharma Co., Ltd.
  • Avanscure Lifesciences Pvt. Ltd.
  • Corden Pharma International GmbH
  • Fresenius Kabi AG
  • Guilin Huiang Biochemistry Pharmaceutical Co., Ltd.
  • Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
  • Indena S.p.A.
  • Intas Pharmaceuticals Ltd.
  • Intelicure Lifesciences
  • LGM Pharma
  • Mac-Chem Products (India) Pvt. Ltd.
  • Novasep Holding SAS
  • Panacea Biotec
  • Phyton Biotech
  • Poly Medicure Ltd.
  • Samyang Holdings Corporation
  • Teva API, Inc.
  • Trumac Healthcare
  • Yunnan Hande Bio-tech Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 466.21 Million
Forecasted Market Value ( USD ) by 2030 $ 822.92 Million
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Bulk Paclitaxel - Global Strategic Business Report - Product Image

Bulk Paclitaxel - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Paclitaxel Injection Global Market Report 2024 - Product Image

Paclitaxel Injection Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Paclitaxel Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Paclitaxel Injection Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Paclitaxel Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Paclitaxel Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 102 Pages
  • Global
From
Paclitaxel. Sources, Chemistry, Anticancer Actions, and Current Biotechnology - Product Image

Paclitaxel. Sources, Chemistry, Anticancer Actions, and Current Biotechnology

  • Book

About the Paclitaxel Market

Paclitaxel is a chemotherapy drug used to treat breast cancer. It is a semi-synthetic derivative of the natural product Taxol, which is extracted from the bark of the Pacific yew tree. Paclitaxel works by interfering with the normal process of cell division, preventing cancer cells from dividing and growing. It is typically used in combination with other drugs, such as doxorubicin, to treat advanced stages of breast cancer. Paclitaxel is available in both intravenous and oral formulations, and is often used in combination with other drugs to treat metastatic breast cancer. It is also used to treat other types of cancer, such as ovarian and lung cancer. Paclitaxel is marketed by several pharmaceutical companies, including Bristol-Myers Squibb, Pfizer, and Sanofi. It is also available as a generic drug in some countries. Companies in the Paclitaxel market include Bristol-Myers Squibb, Pfizer, Sanofi, Mylan, Teva Pharmaceuticals, and Apotex. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.